Your browser doesn't support javascript.
loading
Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults.
Claeys, Carine; Drame, Mamadou; García-Sicilia, José; Zaman, Khalequ; Carmona, Alfonso; Tran, Phu My; Miranda, Mariano; Martinón-Torres, Federico; Thollot, Franck; Horn, Michael; Schwarz, Tino F; Behre, Ulrich; Merino, José M; Sadowska-Krawczenko, Iwona; Szymanski, Henryk; Schu, Peter; Neumeier, Elisabeth; Li, Ping; Jain, Varsha K; Innis, Bruce L.
  • Claeys C; GSK, Clinical Research and Development, Wavre, Belgium. carine.x.claeys@gsk.com.
  • Drame M; GSK, Clinical Evidence Generation (CEG), King of Prussia, PA, USA.
  • García-Sicilia J; Hospital Universitario HM Sanchinarro, Clinical Investigation in Vaccines Unit, Madrid, Spain.
  • Zaman K; icddr,b, MCHD Administration, Dhaka, Bangladesh.
  • Carmona A; Instituto Hispalense de Pediatría, Pediatría, Sevilla, Spain.
  • Tran PM; Cabinet Médical Tran, Pédiatrie, Nice, France.
  • Miranda M; Antequera Hospital, UGC de Pediatría, Málaga, Spain.
  • Martinón-Torres F; Department of Pediatrics, Santiago de Compostela, Hospital Clínico Universitario de Santiago, Translational Pediatrics and Infectious Diseases, Galicia, Spain.
  • Thollot F; Instituto de Investigación Sanitaria de Santiago and Universidade de Santiago de Compostela (USC), Grupo de Investigación en Genética, Vacunas, Infecciones y Pediatría (GENVIP), Galicia, Spain.
  • Horn M; Association Française de Pédiatrie Ambulatoire (AFPA), Pédiatrie, Essey-les-Nancy, France.
  • Schwarz TF; Dr. med. Michael R. Horn Office, Pediatrics, Schoenau am Koenigssee, Germany.
  • Behre U; Klinikum Würzburg Mitte, Standort Juliusspital, Central Laboratory and Vaccination Centre, Würzburg, Germany.
  • Merino JM; Ulrich Behre, Practice, Kehl, Germany.
  • Sadowska-Krawczenko I; Pediatric Department, Hospital Universitario de Burgos, Burgos, Spain.
  • Szymanski H; Department of Obstetrics and Gynecology, Faculty of Medicine, Nicolaus Copernicus University in Torun, Collegium Medicum in Bydgoszcz, Torun, Poland.
  • Schu P; Department of Neonatology, University Hospital No 2, Bydgoszcz, Poland.
  • Neumeier E; NZOZ, Praktyka Lekarza, Oborniki Slaskie, Poland.
  • Li P; GSK, Global Industrial Operations, Dresden, Germany.
  • Jain VK; GSK, Global Industrial Operations, Dresden, Germany.
  • Innis BL; GSK, Clinical Evidence Generation (CEG), King of Prussia, PA, USA.
BMC Infect Dis ; 18(1): 186, 2018 04 18.
Article en En | MEDLINE | ID: mdl-29669531
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Vacunas de Productos Inactivados Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Vacunas de Productos Inactivados Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article